IMR Press / RCM / Volume 20 / Issue 2 / DOI: 10.31083/j.rcm.2019.02.5151
Open Access Review
Metabolic cardiomyopathy in pediatrics
Show Less
Federal State Budgetary Educational Institution of Higher Education "Kuban State Medical University" The Ministry of Health of the Russian Federation, 4, Sedina Str., Krasnodar, Russia, 350063
*Correspondence: (Victoria E. Tril)
Rev. Cardiovasc. Med. 2019, 20(2), 73–80;
Submitted: 15 May 2019 | Accepted: 28 June 2019 | Published: 30 June 2019
Copyright: © 2019 Tril et al. Published by IMR Press.
This is an open access article under the CC BY-NC 4.0 license (

Currently, the percentage of non-specific myocardial lesions of non-inflammatory genesis has significantly increased in the structure of cardiovascular diseases in children and adolescents. Cardiomyopathies are a cluster of myocardial diseases that have become more of interest by cardiologists, morphologists, geneticists, and cardiac surgeons. Cardiomyopathies in children are regarded as a severe pathology characterized by a progressive course, resistance to therapy, and result in an unfavourable prognosis. The current article presents data from international publications dedicated to cardiomyopathy diagnostics in children. This article deals with terminology issues in compliance with international disease classification, primary diagnostic criteria of non-coronary myocardium pathology, and modern methods of diagnostics and pharmacotherapy.

metabolic disorders
heart failure
Figure 1.
Back to top